Article

 

BissonWilliamEnvironMoleToxIntestineSelectiveFarnesoid(Supplementary Figures 1-17, Supplementary Tables 1-3 and Supplementary Reference).pdf Public Deposited

Analytics

Downloadable Content

Download PDF
https://ir.library.oregonstate.edu/concern/articles/mc87ps24z

Descriptions

Attribute NameValues
Creator
Abstract
  • The farnesoid X receptor (FXR) regulates bile acid, lipid and glucose metabolism. Here we show that treatment of mice with glycine-b-muricholic acid (Gly-MCA) inhibits FXR signalling exclusively in intestine, and improves metabolic parameters in mouse models of obesity. Gly-MCA is a selective high-affinity FXR inhibitor that can be administered orally and prevents, or reverses, high-fat diet-induced and genetic obesity, insulin resistance and hepatic steatosis in mice. The high-affinity FXR agonist GW4064 blocks Gly-MCA action in the gut, and intestine-specific Fxr-null mice are unresponsive to the beneficial effects of Gly-MCA. Mechanistically, the metabolic improvements with Gly-MCA depend on reduced biosynthesis of intestinal-derived ceramides, which directly compromise beige fat thermogenic function. Consequently, ceramide treatment reverses the action of Gly-MCA in high-fat diet-induced obese mice. We further show that FXR signalling in ileum biopsies of humans positively correlates with body mass index. These data suggest that Gly-MCA may be a candidate for the treatment of metabolic disorders.
Rights Statement
Additional Information
  • description.provenance : Approved for entry into archive by Patricia Black(patricia.black@oregonstate.edu) on 2015-12-16T21:57:37Z (GMT) No. of bitstreams: 3 license_rdf: 1370 bytes, checksum: cd1af5ab51bcc7a5280cf305303530e9 (MD5) BissonWilliamEnvironMoleToxIntestineSelectiveFarnesoid.pdf: 2888956 bytes, checksum: 0ca708562126043797b8109fdbed8e52 (MD5) BissonWilliamEnvironMoleToxIntestineSelectiveFarnesoid(Supplementary Figures 1-17, Supplementary Tables 1-3 and Supplementary Reference).pdf: 16936805 bytes, checksum: 7877fdd521ba22c062faf91763311ee6 (MD5)
  • description.provenance : Submitted by Patricia Black (patricia.black@oregonstate.edu) on 2015-12-16T21:57:18Z No. of bitstreams: 3 license_rdf: 1370 bytes, checksum: cd1af5ab51bcc7a5280cf305303530e9 (MD5) BissonWilliamEnvironMoleToxIntestineSelectiveFarnesoid.pdf: 2888956 bytes, checksum: 0ca708562126043797b8109fdbed8e52 (MD5) BissonWilliamEnvironMoleToxIntestineSelectiveFarnesoid(Supplementary Figures 1-17, Supplementary Tables 1-3 and Supplementary Reference).pdf: 16936805 bytes, checksum: 7877fdd521ba22c062faf91763311ee6 (MD5)
  • description.provenance : Made available in DSpace on 2015-12-16T21:57:37Z (GMT). No. of bitstreams: 3 license_rdf: 1370 bytes, checksum: cd1af5ab51bcc7a5280cf305303530e9 (MD5) BissonWilliamEnvironMoleToxIntestineSelectiveFarnesoid.pdf: 2888956 bytes, checksum: 0ca708562126043797b8109fdbed8e52 (MD5) BissonWilliamEnvironMoleToxIntestineSelectiveFarnesoid(Supplementary Figures 1-17, Supplementary Tables 1-3 and Supplementary Reference).pdf: 16936805 bytes, checksum: 7877fdd521ba22c062faf91763311ee6 (MD5) Previous issue date: 2015-12-15

Relationships

Parents:

Items

Thumbnail Title Date Uploaded Visibility Actions
BissonWilliamEnvironMoleToxIntestineSelectiveFarnesoid_Supplementary_Figures_1-17__Supplementary_Tables_1-3_and_Supplementary_Reference_.pdf 2017-07-26 Public